MAP1LC3A and Alzheimer disease: Further detection results showed that the expression of the lysosomal markers Lamp1 and CTSB decreased significantly, and the co-localization of LC3 and Lamp1 reduced in the AD group than the control group, suggesting the block in the fusion of APs and lysosomes, or the decrease of lysosome number and function.